Boca Bio’s vertically integrated platform with a data-centric modality provides true end to end solutions for accelerating the realization of cutting edge biotechnological advancements. BocaBio is building the world’s first and largest, multi-national, commercial biobank. We are targeting multiple disease states, including cardiovascular disease, gastrointestinal diseases, neuro-degenerative disease but with a focus on oncology. We partner with the top 20 pharmaceutical and diagnostic companies to identify new drug targets and develop companion diagnostics (CDx). Our CAP accredited reference laboratory provides genetic testing and molecular diagnostic services to patients and physicians in order to expand access to precision medicine, globally. We also leverage this service for our Dx clients and act as a comparative testing facility for existing and next generation platforms and assays. Our Clinical Research Services division has the experience, knowledge and commitment to providing the level of service and hands-on approach that our clients need in order to bring these live changing medical devices and therapies to market. Our global reach extends to over 5 continents and dozens of countries. We are passionate about transforming patients’ lives and understand that we can accomplish this by driving the science of our clients forward. We believe that good business means a better world. With the right partner, advancements in research are possible. BocaBio... Driving Science Forward.